GENETIC TESTING for HEREDITARY CANCER SYNDROMES Resource Guide
Patient Risk Assessment Bracanalysis Colaris Melaris Colaris AP The Testing Process Billing and Insurance Outreach Materials Clinical References and Resources

Comprehensive BRACAnalysis®
GENETIC VARIANT, FAVOR POLYMORPHISM

This result means that the test identified a common genetic change in BRCA1 or BRCA2 that is presumed, but not yet conclusively proven, to be unrelated to hereditary cancer risk. The term polymorphism refers to benign genetic variations that are present in at least 1% of the general population and are unrelated to a significantly increased risk of disease. A patient with this result should be managed in the same manner as a patient with a no mutation detected result. Click here for information on a no mutation detected result.

Download the Results Patient Education Tool
BRACAnalysis® No Mutation Detected or Favor Polymorphism

A favor polymorphism result may be reclassified as a definitive no mutation detected by Myriad in the future. If this occurs, Myriad will issue an amended report to the healthcare provider who ordered the test.


« Back to the BRACAnalysis® Test Results page



© 2004-06, Myriad Genetic Laboratories, Inc.

Introduction
Informed Consent Case Study
Want to know more?
Background
BRCA1 and BRCA2 Genes
Cancer Risk
Testing Guidelines
Test Results and Medical Management